The U.S. Food and Drug Administration is expected to authorize a third dose of the COVID-19 vaccine for those with weakened immune systems as soon as Thursday, the New York Times reported Wednesday night.

The emergency-use authorization would apply to both the Pfizer
PFE,
-3.90%

-BioNTech
BNTX,
-13.76%

and Moderna
MRNA,
-15.64%

vaccines, and would benefit those who have had organ transplants or certain immunodeficiencies, the Times reported.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News